Chronisch Vermoeidheidssyndroom: diagnose, behandeling en ...

122 Chronic Fatigue Syndrome KCE reports 88
114. Peterson PK, Shepard J, Macres M, Schenck C, Crosson J, Rechtman D, et al. A controlled
trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med. 1990;89:554-
60.
115. Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, Tymms K, Wakefield D, Dwyer J, et al.
Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue
syndrome. Am J Med. 1997;103(1):38-43.
116. Brook MG, Bannister BA, WR. W. Interferon-alpha therapy for patients with chronic fatigue
syndrome. J Infect Dis. 1993;168:791-2.
117. See D, Tilles J. Alpha-Interferon treatment of patients with chronic fatigue syndrome.
Immunol Invest. 1996;25:153-64.
118. Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P, et al. A controlled
clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue
syndrome. Clin Infect Dis. 1994;18(Suppl 1):S88-95.
119. Andersson M, Bagby JR, Dyrehag L, C. G. Effects of staphylococcus toxoid vaccine on pain
and fatigue in patients with fibromyalgia/chronic fatigue syndrome. Eur J Pain. 1998;2:133-42.
120. Zachrisson O, Regland B, Jahreskog M, Jonsson M, Kron M, CG. G. Treatment with
staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled
trial. Eur J Pain. 2002;6:455-66.
121. Iwakami E, Arashima Y, Kato K, Komiya T, Matsukawa Y, Ikeda T, et al. Treatment of chronic
fatigue syndrome with antibiotics: pilot study assessing the involvement of Coxiella burnetii
infection. Intern Med. 2005;44(12):1258-63.
122. Vermeulen RCW, Scholte HR. Azithromycin in chronic fatigue syndrome (CFS), an analysis
of clinical data. J Transl Med. 2006;4:34.
123. Endresen GKM. Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.
Rheumatol Int. 2003;23(5):211-5.
124. Akhyani M, Ehsani AH, Ghiasi M, Jafari AK. Comparison of efficacy of azithromycin vs.
doxycycline in the treatment of rosacea: a randomized open clinical trial. Int J Dermatol.
2008;47(3):284-8.
125. Bakar O, Demircay Z, Gurbuz O. Therapeutic potential of azithromycin in rosacea. Int J
Dermatol. 2004;43(2):151-4.
126. Bergman M, Huikko S, Huovinen P, Paakkari P, Seppala H, Finnish Study Group for
Antimicrobial R. Macrolide and azithromycin use are linked to increased macrolide resistance
in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2006;50(11):3646-50.
127. Voils SA, Evans ME, Lane MT, Schosser RH, Rapp RP. Use of macrolides and tetracyclines for
chronic inflammatory diseases. Ann Pharmacother. 2005;39(1):86-94.
128. Food and Drug Administration. Medication Guide about using antidepressants in children and
teenagers. In: US Department of Health and Human Services, editor.; 2006.
129. Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce
the symptoms of chronic fatigue syndrome? Am J Med. 2006;119(2):167.e23-30.
130. McDermott C, Richards SCM, Thomas PW, Montgomery J, Lewith G. A placebo-controlled,
double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in
chronic fatigue syndrome. QJM. 2006;99(7):461-8.
131. The GKH, Bleijenberg G, van der Meer JWM. The effect of acclydine in chronic fatigue
syndrome: A randomized controlled trial. PLoS Clinical Trials. 2007;2(5).
132. Van Houdenhove B, Verheyen L, Pardaens K, Luyten P, Van Wambeke P. Rehabilitation of
decreased motor performance in patients with chronic fatigue syndrome: should we treat
low effort capacity or reduced effort tolerance? Clinical Rehabilitation. 2007;21:1121-42.
133. Knoop H, Bleijenberg G, Gielissen MFM, Van der Meer JWM, White PD. Is a full recovery
possible after cognitive behavioural therapy for chronic fatigue syndrome? . Psychother
Psychosom 2007;76:171-76.